@FiercePharma: Should Sharfstein's temp replacement get the job? Article | Follow @FiercePharma
> Johnson & Johnson sold its St. Joseph's aspirin brand to a closely held Baltimore company for an undisclosed sum, the companies said. Report
> Valeant Pharmaceuticals said it expects to report quarterly results that could exceed what analysts on average had expected and issued a 2011 outlook that topped their forecasts. News
> Novartis said the European Commission has approved broader application of its Lucentis drug to treat visually impaired patients, giving sales of the drug a potential boost. Story
> Speciality pharmaceutical firm IS Pharma Plc said it would buy Switzerland-based Helsinn Healthcare's Irish commercial operations for 4.4 million euros ($5.72 million) to expand its business in Europe. Item
> A chemical leak has sickened 62 workers at a pharmaceutical factory in eastern China. Article
> Celgene's CEO has a message for long term investors: You would do well to stick with us through 2015 and beyond. Report
> Teva Pharmaceutical Industries is "very much on track" to meet its 2015 financial targets and toned down its language about searching for acquisitions in Brazil. Story
> The global market for medical apps for mobile phones look set to have doubled last year to reach $84.1 million, according to market research firm Kalorama, which attributes the rise to greater use of smartphones by healthcare professionals. News
Biotech News
@FierceBiotech: Biogen Idec taps two ex-CEOs to head R&D, corporate development. Story | Follow @FierceBiotech
@JohnCFierce: I really want to see the FDA deliver those CRL letters to the public. Long, long overdue. | Follow @JohnCFierce
> Adventrx announces $22.5M capital raise, mulls acquisition. Article
> Frazier: Merck to make "tough" spending decisions. Report
> Ardea's Phase II gout drug shows promise. Story
> Amgen licenses Xencor's early-stage autoimmune drug. News
And Finally... Republican efforts to scrap President Barack Obama's healthcare reform took a hit on Thursday when budget analysts said repeal would add billions of dollars to the federal budget deficit. Report